Technical Analysis for MDWD - MediWound Ltd.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
3.03 | 1.00% | 0.03 |
MDWD closed up 0.33 percent on Wednesday, February 19, 2020, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
Earnings due: Feb 25
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Flat | Up |
| Historical MDWD trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 1.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 1.00% | |
| Narrow Range Bar | Range Contraction | 1.00% | |
| NR7 | Range Contraction | 1.00% | |
| NR7-2 | Range Contraction | 1.00% | |
| Lower Bollinger Band Walk | Weakness | 1.00% | |
| Stochastic Buy Signal | Bullish | 1.34% | |
| NR7 | Range Contraction | 1.34% | |
| Lower Bollinger Band Walk | Weakness | 1.34% | |
| Inside Day | Range Contraction | 1.34% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/25/2020
- Sector: Healthcare
- Industry: Biotechnology
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the treatment of severe burns, chronic and other hard-to-heal wounds, and connective tissue disorders. Its lead product candidate is EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Medicine Biopharmaceutical Clinical Medicine Burns Medical Emergencies Acute Pain Connective Tissue Debridement Wound
Medicine Biopharmaceutical Clinical Medicine Burns Medical Emergencies Acute Pain Connective Tissue Debridement Wound
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.74 |
| 52 Week Low | 2.5483 |
| Average Volume | 61,988 |
| 200-Day Moving Average | 3.25 |
| 50-Day Moving Average | 3.03 |
| 20-Day Moving Average | 3.03 |
| 10-Day Moving Average | 3.00 |
| Average True Range | 0.09 |
| ADX | 17.41 |
| +DI | 11.02 |
| -DI | 13.36 |
| Chandelier Exit (Long, 3 ATRs ) | 2.87 |
| Chandelier Exit (Short, 3 ATRs ) | 3.19 |
| Upper Bollinger Band | 3.11 |
| Lower Bollinger Band | 2.95 |
| Percent B (%b) | 0.3 |
| BandWidth | 5.43 |
| MACD Line | -0.01 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0081 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.06 | ||||
| Resistance 3 (R3) | 3.06 | 3.05 | 3.05 | ||
| Resistance 2 (R2) | 3.05 | 3.03 | 3.05 | 3.05 | |
| Resistance 1 (R1) | 3.02 | 3.02 | 3.02 | 3.02 | 3.04 |
| Pivot Point | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Support 1 (S1) | 2.98 | 2.99 | 2.98 | 2.98 | 2.96 |
| Support 2 (S2) | 2.97 | 2.98 | 2.97 | 2.95 | |
| Support 3 (S3) | 2.94 | 2.97 | 2.95 | ||
| Support 4 (S4) | 2.94 |
